R1 RCM Inc. (RCM) |
| 14.31 0 (0%) 11-18 16:00 |
| Open: | |
| High: | 14.31 |
| Low: | 14.31 |
| Volume: | 0 |
| Market Cap: | 6,044(M) |
| PE Ratio: | -102.21 |
| Exchange: | NASDAQ Global Select |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 215.55 |
| Resistance 1: | 184.54 |
| Pivot price: | 161.67 |
| Support 1: | 160.92 |
| Support 2: | 146.32 |
| 52w High: | 14.31 |
| 52w Low: | 14.31 |
R1 RCM Inc. leverages technology to provide solutions that both optimize the patient experience and bolster the financial performance of hospitals, health systems, and medical groups. Its core offering is comprehensive revenue cycle management (RCM), meticulously designed to address the entire spectrum of financial complexities faced by healthcare providers. Beyond this holistic approach, R1 RCM also delivers flexible, specialized solutions. These encompass physician advisory services, guiding healthcare organizations on compliant classification of hospital visits (in-patient versus out-patient observation) for billing purposes. Additional modular services include: Practice management: Offering administrative and operational support to streamline patient care, alongside outsourcing of non-essential functions. Revenue integrity: Encompassing critical elements like accurate charge capture, meticulous maintenance of the charge description master, and strategic pricing services. Coding management: Featuring business intelligence and analytical insights, human capital management, robust accountability frameworks, and quality assurance programs. Patient experience enhancements. Business office support. Furthermore, the company provides cloud-based (SaaS) platforms for scheduling and improving patient access. R1 RCM Inc. was established in 2003 and is headquartered in Murray, Utah.
| EPS | 8.620 |
| Book Value | 41.800 |
| PEG Ratio | 0.79 |
| Gross Profit | 40.598 |
| Profit Margin (%) | 18.73 |
| Operating Margin (%) | 21.80 |
| Return on Assets (ttm) | 5.7 |
| Return on Equity (ttm) | 16.9 |
Tue, 02 Jun 2026
R1 Deal Defendants Urge Chancery To Toss Investor Suit - Law360
Wed, 08 Apr 2026
R1 Rcm Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Wed, 04 Feb 2026
R1 Awarded ‘Best in KLAS’ Across Multiple RCM Categories for 2026 - GlobeNewswire
Mon, 02 Feb 2026
NuvemRx Acquires par8o from R1 RCM, Strengthening its Specialty Care Coordination and 340B Referral Capture Capabilities - Business Wire
Wed, 22 Oct 2025
R1 Launches Phare, Healthcare’s First Revenue Operating System - GlobeNewswire
Thu, 25 Sep 2025
$8.9B Deal For Health Tech R1 RCM Draws Del. Chancery Suit - Law360
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |